Anti-p53 (phospho S392) antibody [EP155Y]
- RabMAb
- Lab Essentials
- 20ul selling size
- Recombinant
- What is this?
3
(1 Review)
|
(39 Publications)
Rabbit Recombinant Monoclonal P53 phospho S392 antibody. Suitable for IP, Dot, WB, IHC-P and reacts with Human, Mouse, Rat, Synthetic peptide samples. Cited in 39 publications.
View Alternative Names
P53, TP53, Cellular tumor antigen p53, Antigen NY-CO-13, Phosphoprotein p53, Tumor suppressor p53
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human lung carcinoma tissue sections labeling p53 with Purified ab33889 at 1 : 250 dilution. Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
Unpurified ab33889 at a 1/100 dilution staining p53 in paraffin embedded human prostate adenocarcinoma tissue by Immunohistochemistry.
- IP
Lab
Immunoprecipitation - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
ab33889 (purified) at 1 : 20 dilution (0.6μg) immunoprecipitating p53 in 293T whole cell lysate.
Lane 1 (input) : 293T (Human embryonic kidney epithelial cell) whole cell lysate, 10μg
Lane 2 (+) : ab33889 & 293T whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab33889 in 293T whole cell lysate.
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889)
Predicted band size: 43 kDa
false
- WB
Lab
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889) at 1/2000 dilution
Lane 1:
A431 whole cell lysate at 10 µg
Lane 2:
A431 treated with 1μg/ml doxorubicin for 24 hours whole cell lysate at 10 µg
Lane 3:
A431 treated with 1μg/ml doxorubicin for 24 hours whole cell lysate, the membrane was incubated with alkaline phosphatase at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 43 kDa
Observed band size: 53 kDa
false
Exposure time: 15s
- WB
Lab
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889) at 1/1000 dilution
Lane 1:
HEK-293 (Human embryonic kidney epithelial cell) whole cell lysates at 15 µg
Lane 2:
HEK-293 (Human embryonic kidney epithelial cell) whole cell lysates, then the membrane was incubated with alkaline phosphatase at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 43 kDa
false
- WB
Unknown
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
Lanes 1 and 5 : Extract of Hek293T incubated with etoposide (7.5 μg).
Lanes 2 and 6 : Lambda phosphatase (400 times-diluted)-treated extract of Hek293T incubated with etoposide (7.5 μg).
Lanes 3 and 7 : Lambda phosphatase (100 times-diluted)-treated extract of Hek293T incubated with etoposide (7.5 μg).
Lanes 4 and 8 : Lambda phosphatase (25 times-diluted)-treated extract of Hek293T incubated with etoposide (7.5 μg).
SDS PAGE performed under reducing conditions (100mM DTT, sample heated at 50°C).
Primary :
Lanes 1-4 : Anti p53 (phosphoS392) antibody (ab33889, unpurified) at 1/2000 dilution.
Lanes 5-8 : Anti p53 antibody (ab1101) at 1/2500 dilution.
Secondary :
Lanes 1-4 : HRP-conjugated goat anti-rabbit IgG (H&L) at 1/10000.
Lanes 5-8 : HRP-conjugated goat anti-mouse IgG (H&L) at 1/10000.
Blocked in 5% milk in PBS for 3 hours at room temperature.
Incubated with the primary antibody in 5% BSA + 50mM Tris pH 7.5 + 0.05% Tween-20 overnight at 4°C.
Incubated with the secondary antibody in blocking buffer for 2 hours at room temperature.
All lanes:
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889)
Predicted band size: 43 kDa
Observed band size: 53 kDa
true
Exposure time: 1min
- WB
Lab
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889) at 1/1000 dilution
Lane 1:
HEK-293 whole cell lysate - untreated at 10 µg
Lane 2:
HEK-293 whole cell lysate - treated with Alkaline Phosphatase at 10 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 43 kDa
Observed band size: 43 kDa
false
Exposure time: 15s
- WB
Unknown
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
All lanes:
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889) at 1/500 dilution
Lane 1:
MCF7 cell lysate untreated.
Lane 2:
MCF7 cell lysate treated with 5 ug/ml Actinomycin for 3hrs.
Lane 3:
MCF7 cell lysate treated with 5 ug/ml Actinomycin for 6hrs.
Lane 4:
MCF7 cell lysate treated with 5 ug/ml Actinomycin for 18hrs.
Predicted band size: 43 kDa
Observed band size: 53 kDa
false
- WB
Lab
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889) at 1/1000 dilution
Lane 1:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysates at 15 µg
Lane 2:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysates, then the membrane was incubated with alkaline phosphatase at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 43 kDa
false
- WB
Lab
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889) at 1/1000 dilution
Lane 1:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysates at 15 µg
Lane 2:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysates, then the membrane was incubated with alkaline phosphatase. at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 43 kDa
Observed band size: 53 kDa
false
- Dot
Unknown
Dot Blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
Dot blot analysis of p53 (pS392) peptide (Lane 1) and p53 non-phospho peptide (Lane 2) labelling p53 (pS392) with unpurified ab33889 at a dilution of 1/1000. ab97051 (Peroxidase conjugated goat anti-rabbit IgG (H+L)) was used as the secondary antibody at a dilution of 1/100000.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
Related conjugates and formulations (1)
-
Anti-p53 (phospho S392) antibody [EP155Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P53 functions to control cell division and apoptosis serving as a guardian of the genome by preventing mutation accumulation. It does not form part of a larger complex under normal conditions but interacts with various other molecules to execute its functions. p53 can activate or suppress the transcription of numerous genes involved in cell cycle arrest DNA repair and programmed cell death allowing it to halt the progression of damaged cells and trigger repair mechanisms or eliminate those that cannot be repaired.
Pathways
P53 acts within several key biological pathways such as the p53 signaling pathway and the intrinsic apoptotic pathway. Its activity involves interaction with proteins like MDM2 which regulates p53 through ubiquitin-mediated degradation and ATM kinase which phosphorylates p53 in response to DNA damage. These interactions ensure appropriate cellular responses during stress and are vital for maintaining homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (39)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:23497 PubMed40603406
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and experimental pharmacology & physiology 52:e70022 PubMed39788129
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 14:1433256 PubMed39717750
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomedical optics express 15:4081-4100 PubMed39022556
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e28364 PubMed38596137
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental dermatology 33:e15006 PubMed38284200
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biology of the cell 116:e202300042 PubMed37919852
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 24:2223377 PubMed37370246
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:505 PubMed36720864
2023
Applications
Unspecified application
Species
Unspecified reactive species
Naunyn-Schmiedeberg's archives of pharmacology 396:365-374 PubMed36374307
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com